|
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next
|
|
| |
|
Aug '03
|
|
Early Treatment Extends Life
| |
A study by the Weill Cornell Medical College shows that early antiretroviral therapy for HIV-positive patients may significantly increase life expectancy-- even after accounting for side effects like heightened cholesterol levels. |
|
|
Aug '03
|
|
Once-daily Atazanavir Gets FDA Nod
| |
Bristol-Myers Squibb Co. won the backing of a government advisory panel for atazanavir, a new HIV treatment, after getting favorable comments from reviewers. |
|
|
Jul '03
|
|
SARS Death Rate Higher Among Poz
| |
Luc Montagnier, the French biologist who was the joint discoverer of HIV, voiced fears Monday that the death rate from Severe Acute Respiratory Syndrome (SARS) would be much higher among people who also have HIV/AIDS. |
|
|
Jul '03
|
|
Female Condoms Up the Ass?
| |
The Reality "female condom" was approved in the United States in 1992 for vaginal contraceptive use; it has two flexible polyurethane rings and a thin, loose-fitting polyurethane sheath, demonstrated in laboratory studies to be impermeable to viruses and less likely to rupture
than latex condoms. |
|
|
Jul '03
|
|
Cardio-, Cerebrovascular Risks?
| |
Metabolic abnormalities associated with HIV infection, including dysglycemia and hyperlipidemia, are increasingly prevalent, and there is concern about the possibility of an association with accelerated cardiovascular and cerebrovascular disease. |
|
|
Jun '03
|
|
Clues to How Men Exposed to HIV Stay Virus-Free
| |
According to researchers, men who have sex with HIV-positive women but remain virus-free carry relatively high levels of antibodies that specifically fight HIV infection in the tissue that
first encounters the virus. |
|
|
Jun '03
|
|
Study Looks at Oral Sex
| |
Laboratory studies of mouth tissue suggest that unprotected oral sex does have the potential to transmit HIV, but one expert said it is still less risky than other routes of transmission. |
|
|
Jun '03
|
|
Feds Censor AIDS Grants that Mention 'Gay'
| |
Scientists who study AIDS and other STDs say federal health officials have warned them that their work may come under unusual scrutiny by the Department of Health and Human
Services or members of Congress if its topics are politically controversial. |
|
|
Jun '03
|
|
Virion-Based Vaccine Protects Animals
| |
A DNA vaccine containing viral particles prevents many symptoms of infection in primates exposed to SIV, the simian version of HIV, Maryland researchers reported. |
|
|
Jun '03
|
|
Canada's Prisons: High Risk
| |
A Canadian government report said HIV and hepatitis C infection rates in federal prisons are rising and are at least 10 times higher than in the general population. |
|
|
May '03
|
|
Benefit of Treatment Interruptions Debated
| |
Over the past five years, the argument that HIV-infected people can safely stop taking their medicine for extended periods, and possibly benefit from the breaks, has been
alternately championed and rejected. |
|
|
May '03
|
|
HIV Lessons in Hep C Treatment
| |
Drugs that interfere with HIV have had a major effect in reducing death and disability from AIDS. Now drug companies are beginning to test the first similar drugs for the hepatitis C virus. |
|
|
May '03
|
|
FDA Approves New AIDS Drug
| |
The Food and Drug Administration has approved the first of a new class of HIV drugs, providing, for the first time in seven years, an entirely different mode of attacking the virus. |
|
|
May '03
|
|
Interferon Effective in Patients Coinfected with Hep C
| |
A researcher in Japan has found that interferon (IFN) treatment may be effective for both HIV and hepatitis C virus (HCV) infection. Hideji Hanabusa, working at Ogikubo Hospital in
Tokyo, assessed the efficacy of high-dose IFN therapy in coinfected hemophiliacs. He reported that IFN-treated patients showed significant reductions in levels of both viral pathogens. |
|
|
Apr '03
|
|
Is Heart Disease More Likely? Maybe
| |
At the 10th Conference on Retroviruses and Opportunistic Infections, researchers reported that the risk of a heart attack increases by 26 percent for each year HIV patients remain
on antiviral medicines. |
|
|
Apr '03
|
|
New Treatment Hope
| |
New AIDS medicines in laboratory development or currently in human trials are fueling hopes that a new era of treatment is dawning. |
|
|
Apr '03
|
|
Harmless Virus Linked to Slowing HIV
| |
Infection with a common harmless virus, GBV-C, seems to slow the progress of HIV and prolong survival of AIDS patients, according to evidence reported by American scientists at the
10th Conference on Retroviruses and Opportunistic Infections. |
|
|
Apr '03
|
|
HIV Drug Impresses in Trials
| |
Vertex Pharmaceuticals and GlaxoSmithKline said recently that an experimental HIV drug developed by the companies outperformed or matched popular treatments for the disease in
two separate trials. |
|
|
Apr '03
|
|
Is Heart Disease More Likely? Maybe Not
| |
Newer AIDS drugs available since 1996 do not cause premature heart attacks or stroke as many suspected, a study by San Diego Veterans Affairs and University of California-San
Diego researchers has found. |
|
|
Mar '03
|
|
Scouts Get Free Condoms at International Jamboree
| |
Scouts attending the 20th World Scout Jamboree in Thailand were provided with free condoms on request, Dr. Pipat Yingseri of the Public Health Ministry said. Yingseri said condoms
would be supplied at the event because reports of participants engaging in sex had emerged from past scout gatherings. |
|
|
Mar '03
|
|
Tenofovir Potent Hepatitis B Treatment for HIV-Co-infected Patients
| |
The nucleotide analog tenofovir disoproxil fumarate exhibited potent activity against chronic hepatitis B virus (HBV) infection in patients co-infected with HIV in a prospective pilot
study reported by physicians at the Washington University School of Medicine. |
|
|
Mar '03
|
|
Protease Inhibitors and Heart Health
| |
HOPS is an ongoing prospective observational cohort in which patients have been continuously recruited and followed up since 1992. The study assessed 5,672 HIV-1-infected patients
with a mean age of 42.6 for incidence of myocardial infarction. |
|
|
Mar '03
|
|
Drug Resistant Skin Infection Spreads Among Gay Men in LA
| |
Large, painful skin infections started turning up early last fall among Los Angeles gay men, then appeared with increasing frequency. It took a while to confirm a connection between
the cases, but doctors now know they are facing an emerging epidemic of drug-resistant Staphylococcus aureus, or staph. |
|
|
Mar '03
|
|
MRI Can Find Brain Abnormalities
| |
US researchers found that functional magnetic resonance imaging (fMRI) can offer early warning of neurologic morbidity in HIV patients. |
|
|
Feb '03
|
|
CDC Not Promoting Condom Use
| |
A government fact sheet that long promoted condoms as "highly effective" in preventing HIV and other STDs now offers a more neutral summary of the pros and cons of condom use,
and Congressional Democrats charge that politics are trumping science. |
|
|
Feb '03
|
|
Risk of HIV with Oral Sex: Low
| |
Since HIV was identified as being sexually transmitted, there has been considerable interest in the risk associated with performing fellatio. |
|
|
Feb '03
|
|
Wider Use for Fuzeon?
| |
New test data for the AIDS drug Fuzeon show the drug is most effective in patients still benefiting from at least two other medications. |
|
|
Jan '03
|
|
Musculoskeletal Disorders
| |
People with HIV often experience a wide array of musculoskeletal symptoms secondary to HIV infection. |
|
|
Jan '03
|
|
Once-Daily Quadruple-Drug Therapy
| |
Highly active antiretroviral therapy (HAART) has proved to be effective in suppressing viral load, boosting immunologic function, and improving clinical outcome in HIV infection. |
|
|
Jan '03
|
|
Key T-Cell Subset Loses Efficacy During Treatment Interruptions
| |
Researchers in Italy have reported that antiviral activity from a key T-cell subset is impaired during structured treatment interruptions (STIs) in HIV treatment. |
|
|
|
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next
|
Advertise with us
Subscriptions
Contact us
Site map
Translate
